Xue C - Search Results

1

Pathway Refactoring for Efficient 7-Dehydrocholesterol Production in Saccharomyces cerevisiae.

Han Y, Gao H, Wang S, Ju H, Ge R, Xue C, Liu W, Jiang X, Zhang W. Han Y, et al. Among authors: xue c. ACS Synth Biol. 2025 Jun 27. doi: 10.1021/acssynbio.5c00032. Online ahead of print. ACS Synth Biol. 2025. PMID: 40575831

2

PAMless SpRY exhibits a preference for the seed region for efficient targeting.

Yang C, Zhou Z, Sun X, Ju H, Yue X, Rao S, Xue C. Yang C, et al. Among authors: xue c. Cell Rep. 2024 May 28;43(5):114225. doi: 10.1016/j.celrep.2024.114225. Epub 2024 May 10. Cell Rep. 2024. PMID: 38733582 Free article.

3

Recent advances in CRISPR-Cas9-based genome insertion technologies.

Chen X, Du J, Yun S, Xue C, Yao Y, Rao S. Chen X, et al. Among authors: xue c. Mol Ther Nucleic Acids. 2024 Feb 5;35(1):102138. doi: 10.1016/j.omtn.2024.102138. eCollection 2024 Mar 12. Mol Ther Nucleic Acids. 2024. PMID: 38379727 Free PMC article. Review.

4

SpRY-mediated screens facilitate functional dissection of non-coding sequences at single-base resolution.

Yao Y, Zhou Z, Wang X, Liu Z, Zhai Y, Chi X, Du J, Luo L, Zhao Z, Wang X, Xue C, Rao S. Yao Y, et al. Among authors: xue c. Cell Genom. 2024 Jul 10;4(7):100583. doi: 10.1016/j.xgen.2024.100583. Epub 2024 Jun 17. Cell Genom. 2024. PMID: 38889719 Free PMC article.

5

Clinical outcome and genomic biomarkers of immune checkpoint inhibitor-based therapies for cancer of unknown primary: a multicenter, real-world study.

Huang Y, Huang R, Chen M, Zheng Z, Li H, Chen R, Gao T, Shu D, Hu A, Zheng Q, An X, Shi Y, Xue C. Huang Y, et al. Among authors: xue c. J Cancer Res Clin Oncol. 2025 Jul 12;151(7):213. doi: 10.1007/s00432-025-06261-3. J Cancer Res Clin Oncol. 2025. PMID: 40652145

6

Anticancer Quinolinol Small Molecules Target Multiple Pathways to Promote Cell Death and Eliminate Melanoma Cells Resistant to BRAF Inhibitors.

Wang X, Lama R, Kelleher AD, Rizzo EC, Galster SL, Xue C, Zhang Y, Wang J, Qu J, Chemler SR. Wang X, et al. Among authors: xue c. Molecules. 2025 Jun 22;30(13):2696. doi: 10.3390/molecules30132696. Molecules. 2025. PMID: 40649216

7

Surface-Engineered Umbilical Cord Mesenchymal Stem Cell-Derived sEVs for Targeted Therapy of Osteoarthritis.

Sun Y, Wu H, Chen J, Xue C, Luo J, Wu J, Li S, Li C, Liu T, Pan C, Ding Y. Sun Y, et al. Among authors: xue c. ACS Biomater Sci Eng. 2025 Jul 11. doi: 10.1021/acsbiomaterials.5c00306. Online ahead of print. ACS Biomater Sci Eng. 2025. PMID: 40644710

8

Letter to editor "Predicting NSCLC surgical outcomes using deep learning on histopathological images: development and multi-omics validation of Sr-PPS model".

Lu J, Xue C. Lu J, et al. Among authors: xue c. Int J Surg. 2025 Jul 9. doi: 10.1097/JS9.0000000000002840. Online ahead of print. Int J Surg. 2025. PMID: 40643594 No abstract available.

9

Bitter taste receptor-mediated regulation of glycolipid metabolism and natural product-based targeted therapies: A review.

Bao T, Xue C, Wang Y, Chen J, Dong L, Yang Y, Shi J, Wang Z, Tang R, Wang X, Tong X, Zhao L. Bao T, et al. Among authors: xue c. Int J Biol Macromol. 2025 Jul 8:145759. doi: 10.1016/j.ijbiomac.2025.145759. Online ahead of print. Int J Biol Macromol. 2025. PMID: 40639528 Review.

10

Direct C-C linkage coupled with salt formation: a dual strategy for high-performance tetrazole-based energetic materials.

Yu X, Lei C, Xu Z, Xue C, Tang J, Yang H, Xiao C, Cheng G. Yu X, et al. Among authors: xue c. Mater Horiz. 2025 Jul 10. doi: 10.1039/d5mh00784d. Online ahead of print. Mater Horiz. 2025. PMID: 40637300

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,873 results

Search Page

Filters